The DOI matches its Crossref record; 234 of the 236 references it cites were found in a registry or an index.
Nanomaterial-based blood-brain-barrier (BBB) crossing strategies
Open accessAbstract
Increasing attention has been paid to the diseases of central nervous system (CNS). The penetration efficiency of most CNS drugs into the brain parenchyma is rather limited due to the existence of blood-brain barrier (BBB). Thus, BBB crossing for drug delivery to CNS remains a significant challenge in the development of neurological therapeutics. Because of the advantageous properties (e.g., relatively high drug loading content, controllable drug release, excellent passive and active targeting, good stability, biodegradability, biocompatibility, and low toxicity), nanomaterials with BBB-crossability have been widely developed for the treatment of CNS diseases. This review summarizes the current understanding of the physiological structure of BBB, and provides various nanomaterial-based BBB-crossing strategies for brain delivery of theranostic agents, including intranasal delivery, temporary disruption of BBB, local delivery, cell penetrating peptide (CPP) mediated BBB-crossing, receptor mediated BBB-crossing, shuttle peptide mediated BBB-crossing, and cells mediated BBB-crossing. Clinicians, biologists, material scientists and chemists are expected to be interested in this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“From the physiological point of view, endothelial cells, astroglia, pericytes, and junctional complexes including tight junctions and adherens junctions compose the BBB basically.36–39”
From The blood–brain barrier: Structure, regulation and drug delivery (2023) · cites this paper as [39]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–234 of 234
Towards MR-navigable nanorobotic carriers for drug delivery into the brain
Tabatabaei, S. N., Duchemin, S., Girouard, H., & Martel, S. M. (2012) · Proceedings - IEEE International Conference on Robotics and Automation/Proceedings · doi:10.1109/icra.2012.6225041 · Cited by 44
Mei, L., Zhang, Q., Yang, Y., He, Q., & Gao, H. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.08.020 · Cited by 44
Wen, X., Wang, K., Zhao, Z., Zhang, Y., Sun, T., Zhang, F., Wu, J. H., Fu, Y., Du, Y., Zhang, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106652 · Cited by 44
Yazdan-Shahmorad, A., Tian, N., Kharazia, V., Samaranch, L., Kells, A. P., Bringas, J., He, J.-W., Bankiewicz, K. S., & Sabes, P. N. (2017) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2017.10.009 · Cited by 44
Srivastava, R. A. K. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(03)00006-6 · Cited by 43
The effects of natalizumab on the innate and adaptive immune system in the central nervous system
Stüve, O. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.03.022 · Cited by 43
Novel chemotherapeutic agents for the treatment of glioblastoma multiforme
Jendrossek, V., Belka, C., & Bamberg, M. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.12.1899 · Cited by 43
Lin, H.-C., Ho, M., Tsen, C.-M., Huang, C.-C., Wu, C.-C., Huang, Y.-J., Hsiao, I., & Chuang, C. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx079 · Cited by 43
Chen, Y., Chiang, C., Wu, S., Chen, L., Hsieh, W., & Lin, W.-L. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.05.288 · Cited by 42
Liu, Q., Hou, J., Chen, X., Liu, G.-T., Zhang, D., Sun, H., & Zhang, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102442 · Cited by 41
Self-citationLow-intensity focused ultrasound for the treatment of brain diseases: safety and feasibility
Toccaceli, G., Barbagallo, G. M. V., & Peschillo, S. (2019) · Theranostics · doi:10.7150/thno.31765 · Cited by 41
The identification of leptin-derived peptides that are taken up by the brain
Barrett, G. L., Trieu, J., & Naim, T. (2009) · Regulatory Peptides · doi:10.1016/j.regpep.2009.02.008 · Cited by 40
Toxicological effect of joint cadmium selenium quantum dots and copper ion exposure on zebrafish
Zhang, W., Sun, X., Chen, L., Lin, K., Dong, Q., Huang, C., Fu, R., & Zhu, J. (2012) · Environmental Toxicology and Chemistry · doi:10.1002/etc.1918 · Cited by 39
Lu, Y., Jeong, Y. T., Li, X., Kim, M. J., Park, P., Hwang, S., Son, J. K., & Chang, H. W. (2013) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2013.068 · Cited by 38
Chen, X., Yuan, M., Zhang, Q., Yang, Y. T., Gao, H., & He, Q. (2016) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201017666160401144440 · Cited by 36
Self-citationDual Role of the Metalloprotease FtsH in Biogenesis of the DrrAB Drug Transporter
Li, W., Rao, D. K., & Kaur, P. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.441915 · Cited by 35
Morales‐Cruz, M., Cruz‐Montañez, A., Figueroa, C. M., González-Robles, T. J., Davila, J., Inyushin, M. Y., Loza-Rosas, S. A., Molina, A. M., Muñoz-Perez, L., Kucheryavykh, L. Y., et al. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00461 · Cited by 35
Targeted delivery of large fusion protein into hippocampal neurons by systemic administration
Xiang, L., Zhou, R., Fu, A., Xu, X., Huang, Y., & Hu, C. (2010) · Journal of drug targeting · doi:10.3109/1061186x.2010.523788 · Cited by 32
Veldhorst-Janssen, N. M. L., Fiddelers, A. A. A., van der Kuy, P. H. M., Neef, C., & Marcus, M. A. E. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.12.015 · Cited by 31
O'Donnell, A., Moollan, A., Baneham, S., Önal, M. Ö., Pabari, R. M., Cox, D. M., Kirby, B. P., & Ramtoola, Z. (2014) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12347 · Cited by 29
Joshi, B. H., Leland, P., & Puri, R. K. (2003) · PubMed · Cited by 27
Both Water Intoxication and Osmotic BBB Disruption Increase Brain Water Content in Rats
Kozler, P., RILJAK, V., & Pokorny, J. (2013) · Physiological Research · doi:10.33549/physiolres.932566 · Cited by 27
Cooper, I., Last, D., Guez, D., Sharabi, S., Goldman, S. E., Lubitz, I., Daniels, D., Salomon, S., Tamar, G., Tamir, T., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.6 · Cited by 26
Lee, K. D., Choi, S.-H., Kim, D., Lee, H., & Choi, K. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0489-z · Cited by 24
Hassan, S., Awasthi, N., Li, J., Williams, F., Schwarz, M. A., Schwarz, R. E., & von Holzen, U. W. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.01.022 · Cited by 24
From naturally-occurring neurotoxic agents to CNS shuttles for drug delivery
Soddu, E., Rassu, G., Giunchedi, P., Sarmento, B. F. C. C., & Gavini, E. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.04.005 · Cited by 21
Türkoğlu, Ö. F., Eroğlu, H., Gürcan, O., Bodur, E., Sargon, M. F., Öner, L., & Beşkonaklı, E. (2010) · British Journal of Neurosurgery · doi:10.3109/02688697.2010.487126 · Cited by 20
Getting cancer drugs into the brain
Bender, E. (2018) · Nature · doi:10.1038/d41586-018-06707-4 · Cited by 19
Effect of Functional Magnetic Particles on Radiofrequency Capacitive Heating
Shinkai, M., Ueda, K., Ohtsu, S., Honda, H., Kohri, K., & Kobayashi, T. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00803.x · Cited by 15
Kozler, P., & Pokorny, J. (2012) · PubMed · Cited by 15
Baratta, M. G. (2018) · Nature Nanotechnology · doi:10.1038/s41565-018-0182-3 · Cited by 15
A Method for Evaluating Nanoparticle Transport Through the Blood–Brain Barrier In Vitro
Guarnieri, D., Muscetti, O., & Netti, P. A. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0363-4_12 · Cited by 13
Metastatic brain tumors: current therapeutic options and historical perspective.
Rivkin, M. A., & Kanoff, R. B. (2013) · PubMed · Cited by 12
Salegio, E. A., Campagna, M. V., Allen, P. C., Stockinger, D. E., Song, Y., & Hwa, G. G. C. (2018) · Human Gene Therapy Methods · doi:10.1089/hgtb.2018.049 · Cited by 4
Research works printed but not linked: 1
- Feng, 2017, Self-assembly of gold nanoparticles shows microenvironment-mediated dynamic switching and enhanced brain tumor targeting, Theranostics, 7, 1875, 10.7150/thno.18985 · DOI
Cited by
Sorted by citations
The blood–brain barrier: Structure, regulation and drug delivery
Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906
Self-citationStrategies for delivering therapeutics across the blood–brain barrier
Terstappen, G. C., Meyer, A. H., Bell, R. D., & Zhang, W. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00139-y · Cited by 1,138
Chehelgerdi, M., Chehelgerdi, M., Allela, O. Q. B., Pecho, R. D. C., Narayanan, J., Rao, D. P., Thamaraikani, T., Vasanthan, M., Viktor, P., Lakshmaiya, N., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01865-0 · Cited by 1,132
Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
Montoto, S. S., Muraca, G., & Ruiz, M. E. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.587997 · Cited by 695
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 641
Metadata
- Authors
- Xie, J., Shen, Z., Anraku, Y., Kataoka, K., & Chen, X.
- Affiliations
- Innovation Center of NanoMedicine (JP)
- National Institutes of Health (US)
- Corresponding author
- Shen, Zheyu
- Kataoka, Kazunori
- Chen, Xiaoyuan
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2019-12
- Volume
- 224
- Pages
- 119491
- ISSN
- 0142-9612 (ISSN-L)
- PMC
- PMC6915305
- OpenAlex
- W2973160898
- Cited by
- 604
- References
- 236
- Citations by year
- 2026: 64 · 2025: 131 · 2024: 116 · 2023: 104 · 2022: 92 · 2021: 57 · 2020: 38 · 2019: 2
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Biomaterials (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- blood-brain barrier, BBB crossing, nanomaterials, brain drug delivery, central nervous system disorders, intranasal drug delivery, blood-brain barrier disruption, cell-penetrating peptides, receptor-mediated transcytosis, theranostic agents
- MeSH terms
- Animals, Blood-Brain Barrier, Central Nervous System Diseases, Clinical Trials as Topic, Disease Models, Animal, Humans, Drug Delivery Systems, Nanostructures
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review